The inverse association between IGF1 and all-cause mortality remained consistent across stratification subgroups of clinical risk factors, and such association was more prominent among patients who were premenopausal, with high insulin, with a tumor size >2 cm, with positive lymph node, and with a high Ki-67 level. This evidence concerns the gene IGF1 and neoplasm.